Purdue Pharma controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile5 entries
2024
Supreme Court decision on Sackler releases
The Supreme Court rejected the original bankruptcy settlement because it would have released claims against Sackler family members without the consent of affected claimants. The decision required a revised restructuring process.
2020
Federal criminal resolution
Purdue agreed to plead guilty to federal criminal charges involving opioid marketing and related conduct and entered a substantial civil and criminal resolution with the Department of Justice.
2019
Opioid litigation and bankruptcy
Thousands of opioid-related claims against Purdue led the company to seek Chapter 11 protection. The bankruptcy became a major dispute over corporate accountability and the use of bankruptcy to resolve claims against non-bankrupt owners.
2019
Encinitas sues opioid manufacturers and distributors
Lawsuit filed
The city of Encinitas filed a lawsuit against multiple companies and parties in the opioid industry, alleging that manufacturers and distributors engaged in conduct that led doctors to prescribe opioids and neglected to warn consumers about their addictiveness. The suit named Teva Pharmaceutical Industries USA Inc., Janssen Pharmaceuticals Inc., AmerisourceBergen Corp. and Purdue Pharma's owners, the Sackler family.
Stated objective. Recover costs and tax resources taken from the city and its citizens due to the opioid crisis.
Company response
Denial — Publicis Health
In a statement, a spokesperson with Publicis Health said the lawsuit is “completely without basis.”
Source excerpt
The parties named in the suit include Teva Pharmaceutical Industries USA Inc., Janssen Pharmaceuticals Inc., the AmerisourceBergen Corp. and the Sackler family, the owners of oxycontin manufacturer Purdue Pharma.
The city of Encinitas announced Thursday that it filed a lawsuit against multiple companies and parties in the opioid manufacturing industry, arguing that the city is entitled to economic and health and welfare damages due to the ongoing opioid crisis.
“This lawsuit will seek to recover costs and tax resources taken from the City and its citizens due to the bad acts of the manufacturers and distributors of opioids who caused this ongoing crisis,” said Robins Kaplan attorney Roman Silberfeld.
2007
OxyContin misbranding guilty plea
Purdue Pharma L.P. pleaded guilty to federal misbranding charges based on representations that OxyContin was less addictive, less subject to abuse, and less likely to cause withdrawal than other pain medicines.